Literature DB >> 15574387

The transcription factor Ets-1 in breast cancer.

David W Lincoln1, Kathleen Bove.   

Abstract

The proto-oncogene Ets-1 is a member of the Ets family of transcription factors which share a unique DNA binding domain, the Ets domain. Ets binding sites have been described on the promoters or enhancers of many proteinases and several Ets members transcriptionally regulate such promoters in transient cotransfection assays. Ets-1 is involved in both normal and pathological functions. Ets-1 is expressed in a variety of cells, including endothelial cells, vascular smooth muscle cells and epithelial cells. Ets-1 regulates the expression of several angiogenic and extracellular matrix remodeling factors promoting an invasive phenotype. The Ets family of transcription factors may play a role in the disease progression of breast cancer. In tumors, including breast neoplasia, Ets-1 expression is indicative of poorer prognosis. This review will summarize the role of Ets-1 in both the tumor cells, and the tumor endothelial cells as it relates to breast tumor growth and spread.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15574387     DOI: 10.2741/1546

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  20 in total

1.  Correlated motions and interactions at the onset of the DNA-induced partial unfolding of Ets-1.

Authors:  Hiqmet Kamberaj; Arjan van der Vaart
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

2.  Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.

Authors:  Gang Lu; Qing Zhang; Ying Huang; Jiaxi Song; Ross Tomaino; Tobias Ehrenberger; Elgene Lim; Wenbin Liu; Roderick T Bronson; Michaela Bowden; Jane Brock; Ian E Krop; Deborah A Dillon; Steven P Gygi; Gordon B Mills; Andrea L Richardson; Sabina Signoretti; Michael B Yaffe; William G Kaelin
Journal:  Cancer Cell       Date:  2014-08-11       Impact factor: 31.743

3.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

4.  Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.

Authors:  Priyadharsini Nagarajan; Shu Shien Chin; Dan Wang; Song Liu; Satrajit Sinha; Lee Ann Garrett-Sinha
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

Review 5.  The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

Authors:  Katie Lin; Stavroula Baritaki; Silvia Vivarelli; Luca Falzone; Aurora Scalisi; Massimo Libra; Benjamin Bonavida
Journal:  Antioxidants (Basel)       Date:  2022-06-17

6.  Regulation of alphaB-crystallin gene expression by the transcription factor Ets1 in breast cancer.

Authors:  Joshua D Bosman; Fruma Yehiely; Joseph R Evans; Vincent L Cryns
Journal:  Breast Cancer Res Treat       Date:  2009-02-11       Impact factor: 4.872

7.  Outgrowth of single oncogene-expressing cells from suppressive epithelial environments.

Authors:  Cheuk T Leung; Joan S Brugge
Journal:  Nature       Date:  2012-02-08       Impact factor: 49.962

8.  Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Authors:  Xin-Zhong Chang; Da-Qiang Li; Yi-Feng Hou; Jiong Wu; Jin-Song Lu; Gen-Hong Di; Wei Jin; Zhou-Luo Ou; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  Expression of Tra2 β in Cancer Cells as a Potential Contributory Factor to Neoplasia and Metastasis.

Authors:  Andrew Best; Caroline Dagliesh; Ingrid Ehrmann; Mahsa Kheirollahi-Kouhestani; Alison Tyson-Capper; David J Elliott
Journal:  Int J Cell Biol       Date:  2013-07-08

10.  Localization and Molecular Characterization of human Breast Cancer Initiating Cells from heterogeneous population of Breast Cancer Mesenchymal Stem cells by Immunofluorescence Microscopy.

Authors:  P Potdar; F Monteiro
Journal:  J Stem Cells Regen Med       Date:  2012-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.